SELECT A PRODUCT FROM THE LIST BELOW

Hyaluronidase solution in FertiCult™ Flushing medium

80IU hyaluronidase solution in FertiCult™ Flushing medium
OocyteHandling

Hyaluronidase in FertiCult™ Flushing medium contains 80 IU/ml pharmaceutical grade hyaluronidase from bovine origin, in FertiCult™ Flushing medium (HEPES-buffered medium which contains 4.00g/liter human serum albumin). The product is ready for use.
Hyaluronidase in FertiCultTM Flushing medium is used in the oocyte denudation process. Hyaluronidase digests the hyaluronic acid between the cumulus cells, which makes it easier to remove the cumulus mechanically.

All the products in the FertiCult™ product range undergo strict quality control to comply with the following specifications:

pH 7.3-7.6
Osmolality 270-290 mOsm/kg
Sterility Sterile
Endotoxin < 1.0 EU/mL
Mouse embryo assay ≥ 80% blastocysts after 96h incubation (30 minute exposure at 1-cell stage)
Shelf life 12 months from date of produce

Hyaluronidase in FertiCult™ Flushing medium is CE marked as a Class III medical device according to the European Medical Device Directive.


Product order codes

HYA001 Hyaluronidase solution in Flushing Medium - 5x 1 ml
HYA010 Hyaluronidase solution in Flushing Medium - 10 ml


The product composition can be found in the MSDS (see Resources). Additional information on some components is provided below:

Component Benefit
HEPES (18 mM)

HEPES stabilizes the pH under air (Clark and Swain 2014), therefore CO2 incubation is not required.


HSA (4 g/L)

Hyaluronidase in FertiCult Flushing medium contains 4 g/Liter Human Serum Albumin (HSA) to optimize medium performances. HSA is universally added to most ART media because it is widely considered to be of benefit.

The role of albumin in ART media is extensive, including:
- Stabilization of the cell membrane of the embryo in the medium (Malda, et al. 2008).
- Inhibition of lipid peroxidation that can be damaging to sperm (Alvarez and Storey 1995).
- Carrier and source of essential molecules needed by the embryo (Malda, et al. 2008).
- Detoxification by binding waste products from cell metabolism (Blake, et al. 2004).
- Facilitating gamete/embryo manipulation by preventing adsorption to the surface through saturation of potential binding sites (Blake, et al. 2004).
Hyaluronidase (80IU/ml)

Hyaluronidase in FertiCult Flushing medium contains bovine derived hyaluronidase (80IU/ml). Hyaluronidase is an enzyme derived from bovine testes and is capable of hydrolyzing hyaluronic acid (Tranchepain, et al. 2006), the latter being one of the most abundant constituents of the extracellular matrix (Laurent and Fraser 1992).

When collected, each oocyte is surrounded by a matrix of cells called the cumulus-oocyte complex (COC). The COC is composed of cumulus granulosa cells embedded in a matrix of long hyaluronan oligosaccharide chains cross-linked by a complex of hyaluronan binding cell surface and extracellular matrix proteins and proteoglycans (Richards 2005). In vivo, enzymes like hyaluronidase are released by the acrosome reaction of the sperm cells and dissolve the intracellular matrix between the cumulus cells. Also in vitro during ART, COC around oocytes are removed (i.e. “oocyte denudation”). For that purpose, the European Society of Human Reproduction and Embryology (ESHRE) recommends to use an enzymatic procedure with hyaluronidase, which facilitates the subsequent mechanical denudation process using a pipette (Magli et al. 2008).


Product literature


     Aghaways, IHA., KM. Falah and AA. Ali , The difference in the outcomes between surgically retrieved and ejaculated spermatozoa for Intracytoplasmic Sperm Injection Cycles in Sulaimanyah province., Acta Medica International (2016),Vol.3,No.1,pp.30-38
     Ciepiela, P., T. Baczkowski, A. Drozd, A. Kazienko, E. Stachowska and R. Kurzawa , Arachidonic and linoleic acid derivatives impact oocyte ICSI fertilization-a prospective analysis of follicular fluid and a matched oocyte in a 'one follicle-one retrieved oocyte-one resulting embryo' investigational setting., PLoS One (2015),Vol.10,No.3
     Desquiret-Dumas, V., A. Clement, V. Seegers, L. Boucret, V. Ferre-L'Hotellier, P. E. Bouet, P. Descamps, V. Procaccio, P. Reynier and P. May-Panloup , The mitochondrial DNA content of cumulus granulosa cells is linked to embryo quality., Hum Reprod (2017),Vol.32,No.3,pp.607-614
     Lédée, N.; Lombroso, R.; Lombardelli, L.; Selva, J.; Dubanchet, S.; Chaouat, G.; Frankenne, F.; Foidart, JM.; Maggi, E.; Romagnani, S.; Ville, Y. and Piccinni, M.-P., Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor., Human Reproduction (2008),Vol.23,No.9,pp.2001-2009
     Lédée, N.; Munaut, C.; Sérazin, V.; Perrier d'Hauterive, S.; Lombardelli, L.; Logiodice, F.; Wainer, R.; Gridelet, V.; Chaouat, G.; Frankenne, F.; Foidart, JM; Piccini, M-P., Performance evaluation of microbead and ELISA assays for follicular G-CSF: a non-invasive biomarker of oocyte developmental competence for embryo implantation., Journal of Reproductive Immunology (2010),Vol.86,pp.126-132
     May-Panloup P., Chrétien M.F., Jacques C., Vasseur C., Mathièry Y., Reynier P.,, Low oocyte mitochondrial DNA content in ovarian insufficiency, Human Reproduction (2005),Vol.20,No.3,pp.593-597
     Mitchell V., Steger K., Marchetti C., Herbaut J-C., Devos P., Rigot J-M., Cellular expression of protamine 1 and 2 transcripts in testicular spermatids from azoospermic men submitted to TESE - ICSI, Molecular Human Reproduction (2005),Vol.11,No.5,pp.373-379
     Qassem, E., K. Falah, I. Aghaways and T. Salih , A Correlative Study of Oocytes Morphology with Fertilization, Cleavage, Embryo Quality and Implantation Rates after Intra Cytoplasmic Sperm Injection., Acta Medica International (2015),Vol.2,No.1,pp.7-13
     Sigala, J., C. Sifer, D. Dewailly, G. Robin, A. Bruyneel, N. Ramdane, V. Lefebvre-Khalil, V. Mitchell and C. Decanter, Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study., Fertil Steril (2015),Vol.103,No.1,pp.112-118
     Vidberg, F.; Zeggari, R.; Pieralli, C.; Amiot, C.; Roux, C.; Wacogne, B., Measurement of oocyte temporal maturation process by means of a simple optical micro-system., Sensors and Actuators B: Chemical (2011),Vol.157,pp.19-25


Literature concerning the components


     Alvarez, JG., and BT. Storey, Differential incorporation of fatty acids into and peroxidative loss of fatty acids from phospholipids of human spermatozoa., Mol Reprod Dev. (1995),Vol.42,No.3,pp.334-46
     Blake, D., P. Svalander, M. Jin, C. Silversand, and L. Hamberger., Protein Supplementation of Human IVF Culture Media., Journal of Assisted Reproduction and Genetics (2004),Vol.19,No.3,pp.137-143
     Clark, N.A. and Swain, J.E., Buffering systems in IVF., Culture media, Solutions, and Systems in Human ART, by P. Quinn (2014),pp.30-46
     Laurent, T C., and J R E. Fraser, Hyaluronan, The Journal of the Federation of American Societies for Experimental Biology (1992),pp.2397-2404
     Magli MC, Van den Abbeel E, Lundin K, Royere D, Van der Elst J, Gianaroli L., Revised guidelines for good practice in IVF laboratories, Human Reproduction (2008),pp.1253-1262
     Malda, J. et al., Cell Nutrition, In Tissue engineering, by C. Van Blitterswijk. London, UK: Academia Press, Elsevier, (2008),pp.327-362
     Richards, JS, Ovulation: new factors that prepare the oocyte for fertilization, Molecular and Cellular Endocrinology (2005),Vol.29,pp.75-79
     Tranchepain, F., et al., A complete set of hyaluronan fragments obtained from hydrolysis catalysed by hyaluronidase: appllication of studies of hyaluronan mass distribution by simple HPLC devices., Analytical Biochemistry (2006),pp.232-242

Resources

Click on the links below for more information.